Gabapentin in the treatment of dementia-associated nocturnal agitation

BACKGROUND: Nocturnal sleep of patients suffering from various forms of dementia is often impaired by nocturnal agitation or nocturnal wandering. Anticonvulsives such as carbamazepine or valproate are reported to have some therapeutic efficacy, but there is little information about other drugs suita...

Descripción completa

Detalles Bibliográficos
Autores principales: Buskova, Jitka, Busek, Petr, Nevsimalova, Sona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2011
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628129/
https://www.ncbi.nlm.nih.gov/pubmed/22129906
http://dx.doi.org/10.12659/MSM.882114
_version_ 1782266381491765248
author Buskova, Jitka
Busek, Petr
Nevsimalova, Sona
author_facet Buskova, Jitka
Busek, Petr
Nevsimalova, Sona
author_sort Buskova, Jitka
collection PubMed
description BACKGROUND: Nocturnal sleep of patients suffering from various forms of dementia is often impaired by nocturnal agitation or nocturnal wandering. Anticonvulsives such as carbamazepine or valproate are reported to have some therapeutic efficacy, but there is little information about other drugs suitable for treatment of this condition. CASE REPORT: Our patient, a 77-year-old Czech woman with incipient vascular dementia, received gabapentin 400mg at bedtime for 6 months and showed convincing improvement. CONCLUSIONS: Gabapentin was very effective in treating nocturnal agitation.
format Online
Article
Text
id pubmed-3628129
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-36281292013-04-24 Gabapentin in the treatment of dementia-associated nocturnal agitation Buskova, Jitka Busek, Petr Nevsimalova, Sona Med Sci Monit Case Study BACKGROUND: Nocturnal sleep of patients suffering from various forms of dementia is often impaired by nocturnal agitation or nocturnal wandering. Anticonvulsives such as carbamazepine or valproate are reported to have some therapeutic efficacy, but there is little information about other drugs suitable for treatment of this condition. CASE REPORT: Our patient, a 77-year-old Czech woman with incipient vascular dementia, received gabapentin 400mg at bedtime for 6 months and showed convincing improvement. CONCLUSIONS: Gabapentin was very effective in treating nocturnal agitation. International Scientific Literature, Inc. 2011-12-01 /pmc/articles/PMC3628129/ /pubmed/22129906 http://dx.doi.org/10.12659/MSM.882114 Text en © Med Sci Monit, 2011 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
spellingShingle Case Study
Buskova, Jitka
Busek, Petr
Nevsimalova, Sona
Gabapentin in the treatment of dementia-associated nocturnal agitation
title Gabapentin in the treatment of dementia-associated nocturnal agitation
title_full Gabapentin in the treatment of dementia-associated nocturnal agitation
title_fullStr Gabapentin in the treatment of dementia-associated nocturnal agitation
title_full_unstemmed Gabapentin in the treatment of dementia-associated nocturnal agitation
title_short Gabapentin in the treatment of dementia-associated nocturnal agitation
title_sort gabapentin in the treatment of dementia-associated nocturnal agitation
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628129/
https://www.ncbi.nlm.nih.gov/pubmed/22129906
http://dx.doi.org/10.12659/MSM.882114
work_keys_str_mv AT buskovajitka gabapentininthetreatmentofdementiaassociatednocturnalagitation
AT busekpetr gabapentininthetreatmentofdementiaassociatednocturnalagitation
AT nevsimalovasona gabapentininthetreatmentofdementiaassociatednocturnalagitation

Ejemplares similares